Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical businesses, like the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use - and failure to do so might be grounds for compensation. Our lawyers are operating challenging to get those hurt by the drug the compensation they're entitled to.













image class="left" url="https://images108.fotki.com/v1659/photos/2/3651632/13703394/Xareltobloodthinner140515-vi.jpg"Whilst bleeding is actually a frequent complication linked with anticoagulants, it has been alleged that Xarelto is far more hazardous than classic blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This signifies that, within the event of an emergency, patients may possibly be at threat for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.













If you or perhaps a loved one particular suffered a critical bleeding event following taking Xarelto, you might have legal recourse. For a lot more details, make contact with us these days to possess your case reviewed, free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Furthermore, they are looking for punitive damages, that are typically awarded to punish the defendant and deter other organizations from acting similarly.






Why Are Lawsuits Being Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a secure anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.













Visit this page for far more information on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













image class="left" url="http://media1.picsearch.com/is?dafG5hjeClJ4ZfSbY5KZch_L04pGk3Z3yawikrbATrs&height=176"The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four xareltolaw.bitbucket.org trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki